Antisoma to present at the Rodman and Renshaw conference
10 May 2006, London, UK – Cancer drug developer Antisoma plc (LSE: ASM; USOTC: ATSMY) today announces that Glyn Edwards, its Chief Executive Officer, will present at the Rodman and Renshaw 3rd Annual Global Healthcare Conference on Tuesday 16 May at 13:00 CET in Monte Carlo.
A webcast of the presentation will be available on Antisoma’s website www.antisoma.com. It is recommended that viewers log on 15 minutes early in order to register and download any necessary software. A recorded replay of the presentation will be available after the conference.
Background on Antisoma
Antisoma is a biopharmaceutical company that develops novel products for the treatment of cancer. Antisoma fills its development pipeline by acquiring promising new product candidates from internationally recognised academic or cancer research institutions. Its core activity is the preclinical and clinical development of these drug candidates. Antisoma has a broad strategic alliance with Roche to develop and commercialise products from its pipeline. Please visit www.antisoma.com for further information.
- Contact Information
- Margherita Lupi
- Communications Manager
- Contact via E-mail
This news content was configured by WebWire editorial staff. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.